Testing for Neuroendocrine Immunohistochemical Markers Should Not Be Performed in Poorly Differentiated NSCCs in the Absence of Neuroendocrine Morphologic Features according to the 2015 WHO Classification

Affiliations

¹ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: travisw@mskcc.org.
² Department d'Anatomie et Cytologie Pathologiques, CHU Albert Michallon, University Joseph Fourier, INSERM U823 Institut Albert Bonniot, Grenoble, France.
³ Department of Pathology, Royal Brompton Hospital, London, United Kingdom.

Free article

Comment

William D Travis et al. J Thorac Oncol. 2016 Feb.

Free article

. 2016 Feb;11(2):e26-7.

doi: 10.1016/j.jtho.2015.10.018.

¹ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: travisw@mskcc.org.
² Department d'Anatomie et Cytologie Pathologiques, CHU Albert Michallon, University Joseph Fourier, INSERM U823 Institut Albert Bonniot, Grenoble, France.
³ Department of Pathology, Royal Brompton Hospital, London, United Kingdom.

No abstract available

Comment on

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
Travis WD, Brambilla E, Nicholson AG, Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E, Flieder DB, Geisinger K, Hirsch FR, Ishikawa Y, Kerr KM, Noguchi M, Pelosi G, Powell CA, Tsao MS, Wistuba I; WHO Panel. Travis WD, et al. J Thorac Oncol. 2015 Sep;10(9):1243-1260. doi: 10.1097/JTO.0000000000000630. J Thorac Oncol. 2015. PMID: 26291008
An Unmet Need in the WHO 2015 Biopsy Classification: Poorly Differentiated NSCCs with Positive Neuroendocrine Markers.
Derks JL, Speel EJ, Dingemans AM. Derks JL, et al. J Thorac Oncol. 2016 Feb;11(2):e25-6. doi: 10.1016/j.jtho.2015.10.017. J Thorac Oncol. 2016. PMID: 26811227 No abstract available.